Non Communicable Diseases (NCD)

Non Communicable Diseases (NCD)

Government of India has instituted a comprehensive NCD control program that focus on screening, referral, health promotion and prevention of NCDs and associated risk factors. As part of its commitment to the global target of a 25% reduction in pre-mature mortality from NCD by 2025, MAMTA aims to expand access to NCDs care for the underserved and marginalised population. Since 2011, MAMTA has been designing and implementing integrated-intervention models that are aligned to existing global and national health and development strategic plans through participatory analysis of the situation at individual, community, family and system level.

Adolescents And NCDs

As most of the risk factors of NCDs originate during the adolescence stage, MAMTA with support from ‘SIDA’ and in partnership with Lund University, Sweden and state governments used an opportunity and integrated risk factor component into the existing adolescent reproductive and sexual health to strengthen the health systems for promotion and prevention of NCDs. This initiative set up 15 youth clinics, and trained 120 healthcare professionals including Program Managers, Medical Officers and frontline functionaries in Himachal Pradesh.

Rare Diseases

A disease that occurs infrequently is generally considered a rare diseases (RD). The landscape of rare diseases is constantly changing, as there are new rare diseases and conditions being identified and reported regularly in medical literature. 80% of the rare diseases are genetic in origin and disproportionately affect children. It has been estimated that nearly 50% of reported RDs occur in children, 30% of RDs patients die before the age of 5 years, and 12% of them die between 5 and 15 years of age.

With the support of Takeda, Mamta Health Institute for Mother and Child has implemented a project in the state of Uttar Pradesh, focusing on rare diseases of childhood since November 2021. This was done in collaboration with the UP Chapter of Indian Academy of Pediatrics and the Medical Education department of Uttar Pradesh. As part of this project, the team is strengthening the health system by supporting notified CoE at SGPGI Lucknow aligned with the National Rare Disease Policy 2021.  Mamta-HIMC UP serves as the Technical Support Unit (TSU) for Rare Diseases, supported by Takeda. The State has also set up an Advisory Committee for Rare diseases which comprises of top academicians from reputed institutes. More than 150 Pediatricians from Medical Colleges, Government Hospitals and Private Practitioners have been trained to amplify their capacity for early diagnosis, referral and treatment and the State envisages to work in a Hub and Spoke model by providing services at more centers across the State.

Health System Preparedness For NCDs

Through its Continuum of Care model, MAMTA with support from Medtronic Foundation and state governments conducted a methodological assessment of patient care pathway, and understood both the demand for NCD related healthcare on the part of community, and the capacity for healthcare delivery.

Community Engagement And Health Systems

MAMTA Health Institute for Mother and Child, New Delhi, India with support of Government of Andhra Pradesh has commenced an intervention on integrating Maternal and Child Health services with Prevention and Management of Diabetes and Hypertension in three districts of Andhra Pradesh. This initiative is funded by Bristol-Myers Squibb (BMS) Foundation, USA. The project involved “Arogya Kiran” model which is an innovative mixed approach of ecosystem and patient empowerment. The model empowered and created health promoting environment and self-care management in 400 villages, 200 urban wards, 100 schools and 50 workplaces reached out over 700,000 adolescents and adults.